MedTrace Logo

Breath Volatile Organic Compounds Patterns of Lung Transplant Patients With Chronic Lung Allograft Dysfunction

NCT02836938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2017-02-14

No results posted yet for this study

Summary

It's the aim of this study to clarify, whether the non-invasive assessment of breath can serve as a novel clinical tool to assist in the diagnosis of CLAD. If different stages of BOS can be discriminated by the level of certain VOCs than there would also be a potential to actually predict the development at an early stage and would enable an earlier intervention.

Conditions

  • Chronic Lung Allograft Dysfunction (CLAD)

Interventions

OTHER

Collection of exhaled breath volatile organic compounds

Sponsors & Collaborators

  • Hannover Medical School

    collaborator OTHER

  • Prof. Dr. Jens Hohlfeld

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02836938 on ClinicalTrials.gov